REGENXBIO Inc. Net Income Loss

• REGENXBIO Inc. showed an increase of +14.6% in Net Income Loss from 2024 to 2025.
• This data is from REGENXBIO Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2013 to 2025), REGENXBIO Inc.'s Net Income Loss has declined by 3,499.0%.
• Historical annual values: Fiscal year 2025: -$193.88 million | Fiscal year 2024: -$227.10 million | Fiscal year 2023: -$263.49 million | Fiscal year 2022: -$280.32 million | Fiscal year 2021: $127.84 million | Fiscal year 2020: -$111.25 million | Fiscal year 2019: -$94.73 million | Fiscal year 2018: $99.94 million | Fiscal year 2017: -$73.17 million | Fiscal year 2016: -$62.97 million | Fiscal year 2015: -$22.81 million | Fiscal year 2014: -$4.00 million | Fiscal year 2013: -$5.39 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026